Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
PM & R : the Journal of Injury, Function, and Rehabilitation|October 25, 2019
IncobotulinumtoxinA Treatment in Upper-Limb Poststroke Spasticity in the Open-Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of LifeChristina Marciniak, Michael C Munin, Allison Brashear, et al.Advances in Therapy|November 29, 2018
IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 StudyChristina Marciniak, Michael C Munin, Allison Brashear, et al.Elife|December 26, 2015
A dystonia-like movement disorder with brain and spinal neuronal defects is caused by mutation of the mouse laminin β1 subunit, Lamb1Yi Bessie Liu, Ambika Tewari, Johnny Salameh, et al.Plos One|March 19, 2016
ATP1A3 Mutation in Adult Rapid-Onset AtaxiaKathleen J Sweadner, Camilo Toro, Christopher T Whitlow, et al.Movement Disorders Clinical Practice|July 17, 2018
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter StudyJoseph Jankovic, Daniel Truong, Atul T Patel, et al.Plos One|April 14, 2021
Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b studyAtul T Patel, Mark F Lew, Khashayar Dashtipour, et al.Plos One|February 1, 2021
Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b studyAtul T Patel, Mark F Lew, Khashayar Dashtipour, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 23, 2020
Auditory-perceptual voice and speech evaluation in ATP1A3 positive patientsMary E Moya-Mendez, Lyndsay L Madden, Kathryn W Ruckart, et al.Archives of Physical Medicine and Rehabilitation|July 9, 2004
Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a strokeMartin K Childers, Allison Brashear, Patricia Jozefczyk, et al.Frontiers in Neurology|February 13, 2023
Rapid-onset dystonia-parkinsonism is associated with reduced cerebral blood flow without gray matter changesChristopher T Whitlow, Kyle M Atcheson, Beverly M Snively, et al.Pageof 7